[<i>Yiqi Zishen</i> Formula ameliorates inflammation in mice with chronic obstructive pulmonary disease by inhibiting the PI3K/Akt/NF-κB signaling pathway].
YZF alleviates COPD symptoms and airway inflammation in mice possibly by inhibiting the PI3K/Akt/NF‑κB pathway through its multiple components that interact with multiple targets.
Authors
- Xinguang Liu (ORCID: https://orcid.org/0000-0001-9033-9099)
- Yan Du
- Peng Zhao (ORCID: https://orcid.org/0000-0003-1536-9575)
- Jiansheng Li (ORCID: https://orcid.org/0000-0002-3708-3677)
- Yong‐Xia Wang (ORCID: https://orcid.org/0000-0002-0870-4200)
- Yange Tian
- Liming Wang
- Hongrui Chen
Institutions
- First Affiliated Hospital of Henan University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-07-20
- DOI
- https://doi.org/10.12122/j.issn.1673-4254.2025.07.07
- Citations
- 2
- Primary Topic
- Andrographolide Research and Applications
- Type
- article